CoapTech Announces IDE Approval from FDA to Initiate Clinica

CoapTech announced today it has received an Investigational Device Exemption (IDE) approval from the Food and Drug Administration (FDA) to initiate a clinical trial for its PUMA-G Peds System, a device designed to provide a safer and more efficient way to place feeding tubes in children.

Related Keywords

Presbyterian Hospital , Pennsylvania , United States , Philadelphia , Phil Robilotto , Jack Kent , University Of Maryland , Coaptech Inc , Children National Medical Center , Drug Administration , Office Of Technology , Coaptech Announces , Initiate Clinical Trial , Investigational Device Exemption , Chief Commercialization Officer , National Medical Center , Columbia Newyork Presbyterian , Associate Vice President , Technology Transfer ,